欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/2501/001
药品名称Sitagliptin Aspire
活性成分
    • Sitagliptin phosphate 25.0 mg
剂型Film-coated tablet
上市许可持有人Aspire Pharma (Malta) Limited
参考成员国 - 产品名称Sweden (SE)
Sitagliptin Aspire
互认成员国 - 产品名称
    • Germany (DE)
      Sitagliptin 25 mg Film-coated Tablets
    • Netherlands (NL)
    • Spain (ES)
    • Norway (NO)
      Sitagliptin Aspire
    • Finland (FI)
许可日期2024/12/04
最近更新日期2025/09/09
药物ATC编码
    • A10BH01 sitagliptin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase